Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy
- 1 May 2005
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 15 (3) , 510-516
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Outcome of Endometrial Carcinoma Patients with Involvement of the Uterine SerosaGynecologic Oncology, 2001
- The Significance of Adnexal Involvement in Endometrial CarcinomaGynecologic Oncology, 1999
- The Effect of Postsurgical Therapy on Stage III Endometrial CarcinomaGynecologic Oncology, 1996
- Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine diseaseGynecologic Oncology, 1992
- The significance of positive peritoneal cytology in endometrial cancerGynecologic Oncology, 1992
- The prognostic significance of surgical staging for carcinoma of the endometriumGynecologic Oncology, 1992
- Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total populationInternational Journal of Gynecological Cancer, 1992
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991
- Metastatic and independent cancers of the endometrium and ovary: A clinicopathologic study of 34 casesHuman Pathology, 1985